The effectiveness or the effectiveless of CYP3A4 polymorphism on calsineurin inhibitor drugs trough levels in pediatric kidney transplantations

Basit Öğe Kaydı
dc.contributor.authorToroslu, E.
dc.contributor.authorSozeri, B.
dc.contributor.authorMir, S.
dc.contributor.authorBerdeli, A.
dc.date.accessioned2019-10-27T21:36:51Z
dc.date.available2019-10-27T21:36:51Z
dc.date.issued2011
dc.departmentEge Üniversitesien_US
dc.identifier.endpage1602en_US
dc.identifier.issn0931-041X
dc.identifier.issue9en_US
dc.identifier.startpage1601en_US
dc.identifier.urihttps://hdl.handle.net/11454/46127
dc.identifier.volume26en_US
dc.identifier.wosWOS:000293248800116en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofPediatric Nephrologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe effectiveness or the effectiveless of CYP3A4 polymorphism on calsineurin inhibitor drugs trough levels in pediatric kidney transplantationsen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu